Literature DB >> 14430452

Staphylococcal infection: antitoxic immunity.

H J PARISH, D A CANNON.   

Abstract

Entities:  

Keywords:  STAPHYLOCOCCAL INFECTIONS/immunology

Mesh：

Year:  1960        PMID： 14430452      PMCID： PMC1966868          DOI： 10.1136/bmj.1.5175.743

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  8 in total

1.  Measurement of a staphylococcal antibody in human serum by a mouse protection test.

Authors:  M W FISHER
Journal:  Nature       Date:  1959-06-13       Impact factor: 49.962

2.  [Chemotherapy of non-tuberculous pulmonary infections].

Authors:  C H STUART-HARRIS
Journal:  Br Med J       Date:  1959-06-27

3.  Staphylococcic pneumonia.

Authors:  S EDE; G M DAVIS; F H HOLMES
Journal:  J Am Med Assoc       Date:  1959-06-06

4.  [Scarlet fever caused by Staphylococcus aureus].

Authors:  R C NEGRO; I GENTILE-RAMOS; J GALIANA
Journal:  An Fac Med Univ Repub Montev Urug       Date:  1956 Nov-Dec

5.  On a new method of preparing staphylococcus toxin and toxoid.

Authors:  A TASMAN; J VAN DER SLOT
Journal:  Antonie Van Leeuwenhoek       Date:  1953       Impact factor: 2.271

6.  On the purification and absorption of Staphylococcus toxoid.

Authors:  A TASMAN; A C BRANDWIJK; A MARSEILLE; J D VAN RAMSHORST; J VAN DER SLOT
Journal:  Antonie Van Leeuwenhoek       Date:  1952       Impact factor: 2.271

7.  Staphylococcus toxoid and pustular acne.

Authors:  T C MACDONALD; F TAYLOR
Journal:  Lancet       Date:  1951-09-29       Impact factor: 79.321

8.  STAPHYLOCOCCUS TOXOID: (Annual Review).

Authors:  A Branch
Journal:  Can Med Assoc J       Date:  1938-10       Impact factor: 8.262
  8 in total
  6 in total

1.  Demonstration of an inhibitor of the Muller phenomenon in human sera: its identification as antistaphylokinase.

Authors:  P G QUIE; L W WANNAMAKER
Journal:  J Clin Invest       Date:  1962-01       Impact factor: 14.808

2.  Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infection.

Authors:  Sabine Rauch; Portia Gough; Hwan Keun Kim; Olaf Schneewind; Dominique Missiakas
Journal:  Infect Immun       Date:  2014-09-02       Impact factor: 3.441

3.  Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency.

Authors:  C Tkaczyk; L Hua; R Varkey; Y Shi; L Dettinger; R Woods; A Barnes; R S MacGill; S Wilson; P Chowdhury; C K Stover; B R Sellman
Journal:  Clin Vaccine Immunol       Date:  2012-01-11

Review 4.  Vaccination against pathogenic clostridia in animals: a review.

Authors:  Lida Abdolmohammadi Khiav; Azadeh Zahmatkesh
Journal:  Trop Anim Health Prod       Date:  2021-04-23       Impact factor: 1.559

5.  Nanoparticle-detained toxins for safe and effective vaccination.

Authors:  Che-Ming J Hu; Ronnie H Fang; Brian T Luk; Liangfang Zhang
Journal:  Nat Nanotechnol       Date:  2013-12-01       Impact factor: 39.213

Review 6.  Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform.

Authors:  Pavimol Angsantikul; Soracha Thamphiwatana; Weiwei Gao; Liangfang Zhang
Journal:  Vaccines (Basel)       Date:  2015-10-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.